Clinical Trials
23 trialsNCT07560865 2026-05-01
First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
Masonic Cancer Center, University of Minnesota
Phase 1 Recruiting
NCT05297734 2026-04-30
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Phase NA Recruiting
NCT04678648 2026-03-18
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
Phase 1 Recruiting
NCT02766699 2025-06-03
CerebralEDV
Engeneic Pty Limited
Phase 1 Completed
NCT02392078 2025-04-24
LAANTERN
Monteris Medical
Completed
NCT05551013 2024-08-09
Treatment of Recurrent GBM With APG-157 Via Expanded Access
Aveta Biomics, Inc.
No longer available
NCT02846038 2024-07-25
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
St. Jude Children's Research Hospital
Completed
NCT06480721 2024-06-28
FET-POPPING
UMC Utrecht
Phase NA Not yet recruiting
NCT01651078 2024-04-15
LAASR
Monteris Medical
Completed
NCT02389855 2024-04-12
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Monteris Medical
Completed
NCT02761070 2023-03-08
RE-GEND
Kyorin University
Phase 3 Unknown
NCT05532969 2022-09-27
Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma
Henan Provincial People's Hospital
Not yet recruiting
NCT05536986 2022-09-27
Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma
Henan Provincial People's Hospital
Not yet recruiting
NCT04346472 2020-04-16
SPECIFY
University Hospital, Montpellier
Completed
NCT02715297 2020-03-10
GlioCave/NOA17
Technical University of Munich
Phase 2 Unknown
NCT00108056 2019-12-05
Enzastaurin to Treat Recurrent Brain Tumor
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT00272350 2019-12-05
ZD6474 to Treat Advanced Brain Cancer in Patients
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00201903 2017-04-06
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
Completed
NCT02152748 2017-03-22
Disease Progression and Treatment-induced Alterations in Glioblastoma
Medical University of Vienna
Unknown
NCT00995007 2016-03-29
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00108069 2015-11-05
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01778530 2015-10-07
TRC105 for Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00393094 2012-07-13
Bevacizumab and Irinotecan to Treat Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated